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Introduction
Lamins are nuclear proteins that are components of a fibrous
network underlying the inner nuclear membrane termed the
nuclear lamina, and are also distributed throughout the interior
of the nucleus (reviewed by Goldman et al., 2002). Lamins
have been classified into two types based on biochemical
properties and expression patterns. B-type lamins are
expressed in most cells and are encoded by two separate genes,
B1 and B2, whereas the A-type lamins have been detected
primarily in differentiated cell types. The lamin A gene
(LMNA) encodes lamin A and C transcripts, as well as germ-
cell-specific lamin C2. Lamins belong to the intermediate
filament family of proteins and have a short N-terminal head
domain followed by an -helical rod domain and a globular
tail domain. The C-termini of lamins A, B1 and B2 bear a
CAAX motif that is post-translationally modified and, in the
case of lamin A, is subjected to a further maturation step by
which prelamin A is proteolytically cleaved to give mature
lamin A (reviewed by Stuurman et al., 1998).
Mutations in human LMNA cause several debilitating
diseases, collectively termed laminopathies, that affect skeletal
and cardiac muscle, adipose, bone and neuronal tissues, and
also cause premature ageing syndromes. The majority of
mutations cause autosomal dominant Emery-Dreifuss
muscular dystrophy (EDMD) (Bonne et al., 1999), whereas
other mutations cause dilated cardiomyopathy with conduction
system disease (DCM) (Fatkin et al., 1999), limb girdle
muscular dystrophy (Muchir et al., 2000), or familial partial
lipodystrophy (FPLD) (Shackleton et al., 2000; Cao and
Hegele, 2000). Mutations in LMNA have also been linked to
the relatively rare autosomal recessive disorders Charcot-
Marie-Tooth disorder type 2 (De Sandre-Giovannoli et al.,
2002) and mandibuloacral dysplasia (Novelli et al., 2002), and
more recently to restrictive dermopathy (Navarro et al., 2004).
Many of the above mutations are missense mutations that occur
throughout the gene, although the FPLD mutations are
clustered near the C-terminus. An interesting finding has been
the linkage of mutations in LMNA to Hutchinson-Gilford
progeria syndrome (HGPS) (Eriksson et al., 2003; De Sandre-
Giovannoli et al., 2003) and to atypical Werner’s syndrome
(Chen et al., 2003). The most frequent mutation in HGPS is a
nucleotide substitution (GGC to GGT) that does not cause an
amino acid change (G608G) but activates a cryptic splice site
that leads to a deletion of 50 amino acids near the C-terminus
(residues 607-656), giving rise to a truncated protein termed
lamin A del50 or progerin, which retains the C-terminus of
prelamin A and is not proteolytically processed. A few
missense mutations such as R471C and R527C that do not
affect processing of the C-terminus of lamin A have also been
linked to HGPS and atypical progerias (Eriksson et al., 2003;
Cao and Hegele, 2003). Cells from patients expressing mutant
lamins often exhibit a range of dominant-negative effects such
as abnormal nuclear morphology, aberrant lamin assembly and
altered gene regulation (reviewed by Wilson, 2000; Worman
and Courvalin, 2002; Hutchison and Worman, 2004). HGPS
cells in particular show serious defects in nuclear structure as
well as early senescence (Eriksson et al., 2003; De Sandre-
Giovannoli et al., 2003; Mounkes et al., 2003, Goldman et al.,
2004), and recent reports indicate that HGPS cells and cells
lacking functional Zmpste24, a metalloproteinase required for
A-type lamins are components of the nuclear lamina.
Mutations in the gene encoding lamin A are associated
with a range of highly degenerative diseases termed
laminopathies. To evaluate sensitivity to DNA damage,
GFP-tagged lamin A cDNAs with disease-causing
mutations were expressed in HeLa cells. The inner nuclear
membrane protein emerin was mislocalised upon
expression of the muscular dystrophy mutants G232E,
Q294P or R386K, which aberrantly assembled into nuclear
aggregates, or upon expression of mutants causing progeria
syndromes in vivo (lamin A del50, R471C, R527C and
L530P). The ability of cells expressing these mutants to
form DNA repair foci comprising phosphorylated H2AX in
response to mild doses of cisplatin or UV irradiation was
markedly diminished, unlike the nearly normal response of
cells expressing wild-type GFP-lamin A or disease-causing
H222P and R482L mutants. Interestingly, mutants that
impaired the formation of DNA repair foci mislocalised
ATR (for ‘ataxia telangiectasia-mutated and Rad3-
related’) kinase, which is a key sensor in the response to
DNA damage. Our results suggest that a subset of lamin A
mutants might hinder the response of components of the
DNA repair machinery to DNA damage by altering
interactions with chromatin.
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2705Lamin A mutants hinder DNA repair
prelamin A processing, are defective in DNA repair (Liu et al.,
2005; Varela et al., 2005). Mice that lack intact LMNA develop
severe muscle wasting similar to human EDMD by 3-4 weeks
and die by 8 weeks after birth (Sullivan et al., 1999). Lamin-
deficient cells have defective nuclear mechanics (Lammerding
et al., 2004) and altered gene expression (Nikolova et al.,
2004).
In addition to providing structure and shape to the nucleus,
the lamins are involved in organising several nuclear functions
such as DNA replication (Moir et al., 2000a), RNA polymerase
II (pol II) transcription (Spann et al., 2002; Kumaran et al.,
2002) and mitotic assembly and disassembly. Lamin-
chromatin interactions have also been proposed to have an
important role in nuclear organisation (reviewed by Goldman
et al., 2002). During the late stages of apoptosis, the lamins
are proteolytically cleaved by caspases, which helps to
disassemble the lamina and allows nuclear condensation and
fragmentation to proceed (reviewed by Cohen et al., 2001).
Ectopic expression of various lamin A mutants upon
transfection in cultured cells has been shown to affect normal
lamin assembly and alter the localisation of the inner nuclear
membrane protein emerin, which is involved in lamin-
chromatin interactions (Östlund et al., 2001; Vigoroux et al.,
2001; Raharjo et al., 2001; Holt et al., 2003). Certain mutants
also hinder muscle differentiation and promote cell death upon
serum withdrawal (Favreau et al., 2004; Mariappan and
Parnaik, 2005). Expression of lamin A del50 leads to strongly
dominant-negative effects on nuclear architecture, and blocks
progression of cells through S phase (Goldman et al., 2004).
Although certain lamin A mutants cause cell division defects,
it is not clear whether cells expressing lamin mutants are
affected in their response to DNA-damaging agents.
The initial response to DNA damage involves the chromatin-
dependent activation of complex checkpoint signalling
pathways that delay the cell cycle and repair the defects. The
major kinases that serve as damage sensors and regulate cell-
cycle checkpoints and DNA repair by phosphorylation of key
substrates are ATM (for ‘ataxia telangiectasia mutated’) and
ATR (for ‘ATM and Rad3 related’) kinases that belong to the
phosphoinositide 3-kinase-related family of serine/threonine
protein kinases (reviewed by Zhou and Elledge, 2000;
Abraham, 2001; Bartek et al., 2004). We have examined the
early response of cells expressing disease-causing lamin A
mutants to DNA damage induced by cisplatin or UV, which
primarily cause replicational stress as a result of stalled
replication forks in S phase. A wide range of disease-causing
mutants have been analysed and have been linked to progeroid
syndromes and autosomal dominant forms of EDMD, DCM
and FPLD. We observe that several mutants impair the
formation of phosphorylated H2AX at DNA repair foci and
hinder the recruitment of 53BP1 to repair sites. These mutants
disrupt emerin localisation and, importantly, also mislocalise
ATR kinase in untreated cells. Hence, lamin mutants are likely
to affect the response of the DNA repair machinery to DNA
damage by altered interactions with chromatin.
Results
Localisation of lamin A mutants
The intracellular localisation of mutant lamin A proteins was
determined by transient transfection of fusion constructs
bearing the GFP tag fused to the N-termini of the constructs
into HeLa cells. The assembly of wild-type GFP-lamin A into
a typical nuclear rim pattern has been well documented (Broers
et al., 1999; Moir et al., 2000b). The mutations studied were
E203G, H222P, G232E, Q294P, R386K, R471C, R482L,
R527C, L530P and lamin A del50 (see Fig. 1A for positions
of mutations). In addition to the lamin A del50, R471C and
R527C mutations that cause human progeroid syndromes, mice
homozygous for the L530P mutation show strong progeroid
symptoms (Mounkes et al., 2003), although in humans this
mutation leads to AD-EDMD (Bonne et al., 1999). H222P,
G232E, Q294P and R386K have been identified in AD-EDMD
(Bonne et al., 2000). E203G is mutated in DCM (Fatkin et al.,
1999), and the R482L mutation is found in patients with FPLD
(Shackleton et al., 2000).
Appropriate expression of the mutant proteins was
confirmed by western blot analysis of transfected cell lysates
with antibodies to GFP. None of the constructs yielded
abnormally sized proteins. Lamin A del50 gave a product that
was ~5 kDa smaller than the other constructs, as expected (see
Fig. 1B). Each mutant protein migrated as a doublet and,
except for lamin A del50, the faster migrating band
representing processed lamin A was more prominent.
Microscopic analysis of transfected cells indicated that the
progeroid constructs (R471C, R527C, L530P and lamin A
del50) as well as E203G, H222P and R482L were
predominantly localised to the nuclear periphery (Fig. 1C and
a summary of the data is given in Table 1). However,
Table 1. Summary of effects of ectopically expressed lamin A mutants
Mutant Disease Nuclear location/morphology Emerin ATR -H2AX§
E203G DCM Peripheral*/normal Disrupted Mislocalised Low
H222P AD-EDMD Peripheral/normal Normal Normal Normal
G232E AD-EDMD Aggregates/distorted Disrupted Mislocalised Low
Q294P AD-EDMD Aggregates/distorted Disrupted Mislocalised Low
R386K AD-EDMD Aggregates/distorted Disrupted Mislocalised Low
R471C HGPS Peripheral/few lobulated† Disrupted Mislocalised Low
R482L FPLD Peripheral/normal Normal Normal Normal
R527C HGPS Peripheral/few lobulated† Disrupted Mislocalised Low
L530P AD-EDMD/HGPS Peripheral/few lobulated† Disrupted Mislocalised Low
Del50 HGPS Peripheral/lobulated‡ Disrupted Mislocalised Low
*With small aggregates at the periphery in ~40% of transfected cells.
†10-15% of transfected nuclei, rest normal.
‡60% of transfected nuclei.
§After treatment with cisplatin for 4 hours or UV for 30 minutes.
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expression of lamin A del50 caused extensive changes in
nuclear morphology, resulting in lobulated nuclei in ~60% of
cells, as reported earlier (Goldman et al., 2004), whereas the
number of lobulated nuclei in the other progeroid mutants was
only 10-15%. By contrast, expression of G232E, Q294P and
R386K gave rise to large intranuclear aggregates indicative of
defective assembly, with variable diffuse nucleoplasmic
staining, as observed earlier with FLAG-tagged R386K
(Östlund et al., 2001); the nuclear morphology was also
distorted in many cells. As these assays were done with
transiently transfected cells, a small fraction of cells (~10%)
showing high levels of expression of the less disruptive lamin
constructs, such as H222P, R482L and including wild-type
lamin A, also displayed small aggregates and striated or tubular
Journal of Cell Science 119 (13)
patterns of expression. To minimise overexpression of the
lamin construct, cells were analysed by 24 hours of
transfection. At this time point, the expression of GFP lamin
A was only 20-30% of endogenous lamin A (Fig. 1B). Similar
patterns of localisation were obtained when mutant lamin A
proteins were expressed in the C2C12 mouse myoblast cell line
(data not shown).
Alterations in localisation of emerin
Emerin is an integral nuclear membrane protein that is an
important binding partner for lamin A/C (Clements et al., 2000;
Vaughan et al., 2001), and expression of certain lamin A
mutants in transfected cells can alter its localisation (Östlund
et al., 2001; Raharjo et al., 2001; Vigoroux et al., 2001; Holt
Fig. 1. Assembly properties of
GFP-tagged lamin A constructs.
(A) Domain structure of the lamin
A protein indicating disease-
causing mutations that have been
analysed in this study. (B) Western
blot analysis of HeLa cell lysates
expressing GFP-tagged lamin
constructs, probed with anti-GFP
and anti-lamin A antibodies.
Unprocessed and processed forms
of lamins are indicated by
arrowheads, lamin A del50 is
marked by asterisks, and A and C
indicate lamin A and lamin C.
Molecular mass markers indicated
on the left are: phosphorylase b,
94 kDa; albumin, 67 kDa; and
ovalbumin, 43 kDa.
(C) Immunofluorescence analysis
of GFP-tagged lamin A constructs
transiently transfected into HeLa
cells and counterstained with
DAPI. Ut, untransfected cells;
WT, wild-type GFP-lamin A;
del50, lamin A del50; numbers
represent positions of altered
amino acid residues indicated in
A. Bar, 10 m.
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2707Lamin A mutants hinder DNA repair
et al., 2003). Mutant lamins also bind less efficiently to emerin
in in vitro binding assays (Raharjo et al., 2001). We observed
that expression of G232E, Q294P or R386K mutants resulted
in extensive disruption of emerin staining at the nuclear rim
(Fig. 2A). Furthermore, emerin staining was reduced in a
significant majority of cells expressing E203G, R471C,
R527C, L530P or lamin A del50. In the case of E203G, cells
with small aggregates of mutant lamin at the periphery showed
mislocalisation of emerin. These effects on emerin localisation
were observed in only a small percentage of cells expressing
the H222P and R482L mutants, or wild-type GFP-lamin A, and
a quantitative analysis of these data is shown in Fig. 2B.
Decreased formation of -H2AX foci
An early response to various types of DNA damage is
phosphorylation of histone H2AX, a variant form of the histone
H2A, to give intranuclear -H2AX foci; this is mediated by
ATM, ATR and DNA-dependent protein kinases (reviewed by
Redon et al., 2002). We have tested the ability of HeLa cells
expressing lamin A mutants to respond to DNA damage by
quantitating the formation of DNA repair foci labelled with an
antibody specific for -H2AX. DNA damage was induced after
transient transfection of lamin constructs by treatment of cells
with cisplatin or UV irradiation, which cause replicational
stress. Conditions were standardised so that events occurring
prior to apoptosis and lamin cleavage could be evaluated.
Cisplatin primarily forms intrastrand adducts, which are
recognised by DNA repair proteins, by crosslinking the N7
positions of adjacent purines on the same strand; cisplatin-
induced damage leads to the activation of the ATR checkpoint
signalling pathway (Cliby et al., 1998). The conditions for
cisplatin treatment were initially optimised to ensure that cells
had not entered the apoptotic pathway under the chosen
conditions. When HeLa cells were treated with 25 M
cisplatin over a period of 24 hours, it was observed that there
was significant poly (ADP-ribose) polymerase (PARP-1)
proteolysis, which is considered to be a sensitive marker for
apoptosis, by 16 hours of treatment (Fig. 3A); by 24 hours,
there was complete proteolytic degradation of PARP-1 and
~40% of the cells were apoptotic or dead. Lamin cleavage to
form higher-mobility species and a small proteolytic fragment
was also detectable by 16-24 hours; similar kinetics of
proteolysis was observed with cells transfected with wild-type
GFP-lamin A. By contrast, after 4 hours of cisplatin treatment,
there was no degradation of
PARP-1 or lamins, and ~98% of
cells continued to display a
normal nuclear morphology with
intact peripheral lamina staining
(Fig. 3B); emerin staining was
also normal and there was no
evidence of apoptotic markers
such as cytochrome c release
from mitochondria or labelling
with annexin V in ~98% of cells
(data not shown). Furthermore,
wild-type GFP-lamin A gave a
discrete nuclear rim pattern after
4 hours of treatment (shown in
Fig. 4A), unlike the dispersal of
GFP-lamin A observed at the
onset of nuclear condensation
(Broers et al., 2002). When
untreated cells were stained with
an antibody to -H2AX, <3% of
cells displayed -H2AX foci
(Fig. 3C). After 24 hours of
cisplatin treatment, >95% of
cells formed -H2AX foci,
and nuclear blebbing and
fragmentation were clearly
discernible in ~40% of cells.
After treatment with cisplatin for
4 hours, foci were detectable in
~75% of cells showing normal
nuclear morphology, and only 2-
3% of cells showed intense -
H2AX staining and nuclear
fragmentation and/or blebbing
(similar to that shown in Fig. 3C
for longer time points); these
cells were not counted for the
quantitative analysis as they
Fig. 2. Localisation of emerin.
(A) HeLa cells transfected with the
indicated lamin A constructs were
fixed and stained with antibody to
emerin, and counterstained with
DAPI. Arrowheads indicate
transfected cells showing
mislocalisation of emerin.
(B) Quantitative analysis of
transfected cells showing normal
emerin staining. Bar, 10 m.
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were likely to be apoptotic. The localisation of -H2AX foci
and the incorporation of bromodeoxyuridine into DNA was
coincident in >90% of nuclei after DNA damage (data not
shown), consistent with formation of foci during S phase
described in earlier studies (Cliby et al., 1998; Ward and Chen,
2001).
When cells transfected with wild-type GFP-lamin A were
treated with cisplatin for 4 hours, the number of transfected
cells displaying -H2AX foci was similar to that of
untransfected cells, as shown in Fig. 4A. (Fewer than 3% of
transfected cells displayed foci prior to cisplatin treatment.)
Importantly, cells transfected with E203G, G232E, Q294P,
R386K, R471C, R527C, L530P or lamin A del50 showed a
substantially reduced ability to form -H2AX foci and 70-80%
of transfected cells did not exhibit foci. In cells expressing
other mutants such as H222P and R482L, the extent of foci
formation was nearly similar to that of wild-type GFP-lamin A
or untransfected cells. The similar response with untransfected
cells and cells transfected with wild-type GFP-lamin A
provides evidence that the transfected cells were not under
stressful conditions that might affect their response to DNA
damage. Representative images are displayed in Fig. 4A and a
quantitative analysis of the data is shown in Fig. 4C. There
were no obvious alterations in localisation of GFP lamins after
treatment, although minor changes could not be ruled out.
UV irradiation of cells results in the formation of pyrimidine
dimers that lead to stalled replication forks and activation of
the ATR signalling pathway (Guo et al., 2000; Ward and Chen,
Journal of Cell Science 119 (13)
2001). To check whether formation of -H2AX foci upon UV
irradiation was altered in cells expressing lamin constructs,
transfected HeLa cells were irradiated with UV at 50 J/m2 and
allowed to recover for 30 minutes in fresh medium. Under
these conditions, no significant effects were observed on
nuclear morphology or staining of the peripheral lamina (Fig.
3B) and <3% of cells were apoptotic (Fig. 3C). Furthermore,
there was no detectable cleavage of lamin A or PARP-1 after
30 minutes of recovery (Fig. 3A). Cells transfected with
E203G, G232E, Q294P, R386K, R471C, R527C, L530P or
lamin A del50 showed reduced ability to form -H2AX foci
and 60-75% of transfected cells did not exhibit foci. In cells
expressing other mutants such as H222P and R482L, the extent
of foci formation was nearly similar to that of wild-type GFP-
lamin A or untransfected cells. Representative images are
displayed in Fig. 4B and a quantitative analysis of the data is
shown in Fig. 4D. Interestingly, the individual mutants showed
similar trends for foci formation in response to cisplatin or UV.
As an additional marker for repair sites, we analysed the
localisation of 53BP1, a p53-binding protein that rapidly
redistributes from a diffuse nuclear location to nuclear foci that
co-localise with -H2AX foci in response to various DNA-
damaging agents (Rappold et al., 2001). When HeLa cells were
treated with cisplatin for 4 hours, 53BP1 was predominantly
localised in nuclear foci in ~80% of cells (Fig. 5A). In cells
expressing E203G, G232E, Q294P, R386K, R471C, R527C,
L530P or lamin A del50 mutants, 53BP1 remained diffusely
localised in the majority of cells after cisplatin treatment; by
Fig. 3. Optimisation of treatment
with DNA-damaging agents.
(A) Western blot analysis of
untransfected HeLa cells and cells
transfected with wild-type GFP-
lamin A, treated with cisplatin (CP)
for 0-24 hours, or UV irradiation
with a recovery period of 0.5 or 24
hours, and probed with antibodies
to PARP-1 and lamin A/C.
Arrowheads indicate cleavage
products as a result of apoptosis.
Wild-type GFP-lamin A is
indicated by an asterisk. Molecular
mass markers indicated on the left
are: phosphorylase b, 94 kDa;
albumin, 67 kDa; ovalbumin, 43
kDa; and carbonic anhydrase, 30
kDa. (B) HeLa cells treated with
cisplatin for 4 hours or UV
irradiation with a recovery time of
0.5 hours were stained with
antibody to lamin A/C (LA-2B3).
(C) HeLa cells treated with
cisplatin for 0-24 hours were
stained with antibody to -H2AX,
and counterstained with DAPI.
Arrowheads indicate fragmented
nuclei. Percentages of apoptotic
cells after cisplatin treatment were
<3% (4h), 5% (8h), 15% (16h) and
40% (24h); and after UV
irradiation, <3% (0.5h) and 50%
(24h). Bar, 10 m.
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2709Lamin A mutants hinder DNA repair
contrast, with H222P and R482L mutants or wild-type GFP-
lamin A, recruitment to nuclear foci was observed in most of
the transfected cells (Fig. 5B). A quantitative analysis of the
data is shown in Fig. 5C. Expression of lamin mutants did not
affect the diffuse nuclear staining of 53BP1 in untreated cells
(data not shown). Upon 30 minutes of recovery after UV
irradiation, 53BP1 was localised in very small 53BP1 foci with
a diffuse background (Fig. 5A), so we did not quantitate the
effects of lamin mutants after UV treatment. Importantly, the
lamin mutants that affect 53BP1 redistribution correspond to
those that are impaired in -H2AX production, which is
consistent with the reported requirement of -H2AX for
binding to and recruitment of 53BP1 to repair sites (Ward et
al., 2003).
Aberrant localisation of ATR
To determine whether lamin mutants could affect localisation
of specific signalling components and thus cause an impaired
response to DNA damage, we checked the localisation of ATR
and ATM kinases in cells expressing lamin mutants in
cotransfection studies performed in cells not subjected to
DNA-damaging conditions. Cells expressing FLAG-ATR or
Fig. 4. Formation of -H2AX
foci after DNA damage. HeLa
cells transfected with the
indicated GFP-tagged lamin A
constructs (green) were (A)
treated with cisplatin for 4 hours
or (B) irradiated with UV and
allowed to recover for 0.5 hours,
fixed and stained with antibody
to -H2AX (red) and
counterstained with DAPI. Bar,
10 m. (C,D) Quantitative
analysis of -H2AX staining
with cisplatin-treated and UV-
treated HeLa cells, respectively.
Percentage of untransfected (Ut)
or transfected cells positive
(solid bars) or negative (open
bars) for -H2AX foci are
plotted.
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FLAG-ATM showed a diffuse nuclear staining as described
earlier for both the endogenously and exogenously expressed
kinases; the properties of the exogenous kinases have been
shown to be similar to the endogenous enzymes and their
overexpression does not have deleterious effects (Cliby et al.,
1998; Bakkenist and Kastan, 2003). This normal localisation
of ATR kinase was not affected by expression of wild-type
lamin A, or the H222P and R482L mutants. Interestingly, we
observed a distinct mislocalisation of ATR to the cytoplasm on
expression of G232E, Q294P or R386K, with the majority of
cells showing exclusive cytoplasmic location (shown in Fig.
6A). Although ATR kinase was detected mostly in the nucleus
in cells expressing the E203G, R471C, R527C, L530P or lamin
A del50 mutants, with occasional cytoplasmic localisation, the
number of cells expressing ATR was substantially lower. This
loss of ATR expression was also observed with the G232E,
Q294P and R386K mutants, and a quantitative analysis of the
data is given in Fig. 6C. By contrast, we did not detect
significant changes in the localisation or expression of ATM in
the presence of any of the above mutants (Fig. 6B,C). The
Journal of Cell Science 119 (13)
nuclear localisation or expression of DNA-dependent protein
kinase was also not affected by lamin mutants (data not
shown). We checked whether lamin A is a direct substrate for
phosphorylation by ATR and ATM in a western blot with an
antibody to the phosphorylated target sequence for ATR and
ATM, which is present in the lamin A sequence. We could not
detect phosphorylated lamins after mild DNA damage, i.e.
cisplatin treatment for 4 hours or UV for 30 minutes (data not
shown).
Discussion
We have investigated the ability of cells expressing disease-
causing lamin A mutant proteins to respond to DNA damage.
Our data indicate that HeLa cells expressing several highly
deleterious lamin mutations are impaired in their ability to
form DNA repair foci containing -H2AX in response to
cisplatin or UV irradiation. These mutant lamins displayed
altered localisation of emerin and caused mislocalisation of
ATR kinase in untreated cells. The implications of our results
are discussed with respect to the molecular phenotypes of the
studied mutants and the role of phosphoinositide 3-kinase-
related protein kinases in the repair of DNA damage.
Molecular phenotypes of lamin mutants
The lamin mutants investigated in this study have been linked
to autosomal dominant forms of disease, and could be expected
to exhibit specific phenotypes in the presence of wild-type
endogenous lamin A and C. Our results shows that the AD-
EDMD mutants G232E, Q294P and R386K form aggregates
and are strongly disruptive of lamin assembly. The observed
assembly properties and localisation of ectopically expressed
mutants that have also been studied by other laboratories
(E203G, R386K, R482L, L530P and lamin A del50) are
Fig. 5. Localisation of 53BP1
after DNA damage.
(A) Untreated HeLa cells or
cells treated with cisplatin for 4
hours or UV irradiation with a
recovery time of 0.5 hours were
stained with antibody to 53BP1
and counterstained with DAPI.
(B) HeLa cells transfected with
the indicated GFP-tagged lamin
A constructs (green) were
treated with cisplatin for 4
hours, fixed and stained with
antibody to 53BP1 (red) and
counterstained with DAPI.
Arrows indicate transfected
cells showing diffuse 53BP1
staining. Bar, 10 m.
(C) Quantitative analysis of
cells showing 53BP1 staining
in nuclear foci after cisplatin
treatment. Ut, untransfected.
Jo
ur
n
a
l o
f C
el
l S
cie
nc
e
2711Lamin A mutants hinder DNA repair
consistent with previous reports (Östlund et al., 2001; Bechert
et al., 2003; Goldman et al., 2004; Scaffidi and Misteli, 2005).
Lamin A del50 has been shown to have strongly deleterious
effects on nuclear morphology and chromatin organisation
(Goldman et al., 2004), which have been attributed to retention
of the farnesylated C-terminus. In our study, the expression of
lamin A del50 also gave rise to highly convoluted nuclei with
abnormal morphology, whereas the other progeroid constructs
– R471C, R527C and L530P – were predominantly localised
with smooth staining at the nuclear rim and displayed low
levels of lobulated nuclei. Although L530P has been linked to
AD-EDMD in humans, it gives rise to HGPS-like symptoms
in mice in a knockin experiment; this might be a result of
aberrantly spliced forms of lamin A observed in the mouse
model (Mounkes et al., 2003). However, we did not detect any
products from differentially spliced forms of L530P in western
blots of transfected cell lysates. Constructs such as H222P
predominantly showed a typical nuclear rim localisation and
normal localisation of emerin, consistent with the milder
properties observed in a recently reported knockin mouse
model of AD-EDMD with the H222P mutation (Arimura et al.,
2005). Similar localisation patterns of the mutants were
observed in HeLa and C2C12 cells, although variations in
expression and localisation of lamin mutants in other cell types
cannot be ruled out. There is considerable evidence for the
involvement of lamins in the spatial organisation of RNA pol
II transcription (Spann et al., 2002; Kumaran et al., 2002), and
specific genes are misregulated in HGPS, FPLD and DCM
cells (Csoka et al., 2004; Capanni et al., 2005; Mounkes et al.,
2005). When we analysed RNA pol II transcription in cells
expressing lamin mutants, we did not observe significant
alterations in staining of active pol II (data not shown),
although we cannot rule out effects on transcription of specific
genes.
We have observed that emerin is distinctly mislocalised in
cells expressing mutants like R386K, Q294P and G232E that
form aggregates and are defective in assembly at the nuclear
periphery. Furthermore, emerin levels at the nuclear envelope
were depleted on expression of constructs with mutations at the
C-terminus (R471C, R527C, L530P and lamin A del50), which
might be unable to bind to emerin and localise it to the nuclear
envelope, since emerin has been shown to associate with the
C-terminus of lamin A (Vaughan et al., 2001). Expression of
the DCM mutant E203G, which forms small aggregates at the
periphery in ~40% of cells, also resulted in mislocalisation of
emerin. By contrast, expression of the FPLD mutant R482L
did not alter the nuclear rim localisation of emerin in the
majority of cells. However, co-localisation of lamin and emerin
might not always imply correct intermolecular interactions. In
a previous study with fibroblasts from FPLD cells expressing
this mutant, about 80% of cells showed normal rim localisation
of emerin, whereas 15-20% cells displaying lamin A/C
aggregates showed reduced staining of emerin; binding of
emerin to lamin A but not to lamin C was affected in the FPLD
Fig. 6. Localisation of ATR
and ATM kinases in untreated
cells. (A) HeLa cells
transfected with a FLAG-ATR
construct (ATR) or
cotransfected with the
indicated GFP-tagged lamin A
constructs (green) were fixed
and stained with anti-FLAG
antibody (red), and
counterstained with DAPI.
Arrows indicate cells showing
exclusive cytoplasmic staining
of ATR. (B) As in A, except
that a FLAG-ATM construct
(ATM) was used. Bar, 10 m.
(C) Quantitative analysis of
transfected cells expressing
ATR, including nuclear and/or
cytoplasmic staining (open
bars), or ATM (solid bars),
both normalised to wild type as
100%.
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fibroblasts (Capanni et al., 2003). Emerin is an important
binding partner for lamin A, and also binds to barrier-to-
autointegration factor (BAF), a DNA-binding chromatin
protein (Lee et al., 2001). Emerin and BAF, together with other
lamin-binding proteins such as lamina-associated polypeptide
2 (Dechat et al., 2000), have been proposed to cooperate with
lamins in the spatial organisation of chromatin. An important
correlation we have observed is that the lamin mutants that
show altered localisation of emerin are hindered in their
response to DNA damage and show mislocalisation of ATR
kinase, as discussed in the next section.
Aberrant chromatin organisation has been observed in
various conditions of lamin mis-expression. Expression of
lamin A del50 leads to the depletion of heterochromatin and
abnormal nuclear morphology, which have been attributed to
the accumulation of prelamin A (Goldman et al., 2004). Also,
cardiomyocytes from lamin A/C-deficient mice display
relocalisation of heterochromatin from the periphery to the
interior of the nucleus (Nikolova et al., 2004). Analysis of the
dynamics of various GFP-tagged lamin mutants in live cells
has given further insights into the disparate effects of different
mutations in lamin A and C on lamin organisation and
chromatin structure. Wild-type lamin A and the R482W
mutant, which causes FPLD, showed slow kinetics of
movement at the nuclear periphery, consistent with their
incorporation into a stable polymer (Gilchrist et al., 2004). By
contrast, AD-EDMD mutants in the rod domain as well as
L530P displayed increased dynamics; the rod domain mutants
are likely to be impaired in filament assembly whereas L530P,
being buried in the C-terminal core domain, might destabilise
protein folding. The R482W mutant is surface exposed at the
C-terminus and thus might not affect the structure of the
protein (Dhe-Paganon et al., 2002). In another study,
significant decrease in integration into intranuclear sites was
observed for the R386K mutant, in addition to increased
mobility at the nuclear rim, which was proposed to be a result
of loss of interaction with chromatin (Broers et al., 2005). With
reference to the other mutants we have studied, the structure
of the globular tail domain predicts that substitutions at R527
are likely to perturb structure as a result of disruption of a salt
bridge at the domain surface, whereas those at R471, which is
buried in the domain core, are likely to disrupt protein folding
and stability (Dhe-Paganon et al., 2002). Of the rod domain
mutations we have analysed, G232E and Q294P markedly
affect filament assembly and the mutants form large nuclear
aggregates. E203G also affects filament assembly as small
aggregates are formed in 40% of transfected cells. However,
H222P assembles normally into filaments at the periphery.
Implications for repair of DNA damage
When DNA is damaged by agents such as UV irradiation or
crosslinking agents, this leads to stalled replication forks in S
phase and activation of the ATR pathway (Zhou and Elledge,
2000; Abraham, 2001; Bartek et al., 2004). Treatment with
ionising radiation or certain radiomimetic drugs results in
random double-strand breaks that lead primarily to the
activation of the ATM pathway by autophosphorylation of
ATM, with a requirement for ATR kinase also in this response
(Shiloh, 2003; Bakkenist and Kastan, 2003). Furthermore,
ATR appears to carry out genome surveillance functions in
normal cell cycles (Ward and Chen, 2001). Defects in ATR
Journal of Cell Science 119 (13)
or ATM signalling pathways are highly deleterious. ATR-
knockout mice are embryonic lethal (Brown and Baltimore,
2003) and a hypomorphic mutation in ATR has been linked to
the human disease Seckel syndrome in which there is severe
growth retardation as well as skeletal and brain abnormalities
(O’Driscoll et al., 2003). In humans, lack of ATM results in
ataxia telangiectasia, which is characterised by neuronal
degeneration, immunodeficiency, premature ageing and a
predisposition to cancer; similar abnormalities are seen in
ATM-null mice (Shiloh, 2003). In the absence of the gene
encoding H2AX in mice, cells show increased genomic
instability and more sensitivity to DNA damage, and are
impaired in the formation of DNA repair foci. Prevention of
H2AX phosphorylation by specific kinase inhibitors also
blocks the formation of DNA repair foci, and recruitment of
other repair proteins such as BRCA1, Nbs1, 53BP1, RAD50
and RAD51 to sites of DNA damage (Redon et al., 2002). DNA
repair pathways are also defective in cells accumulating
prelamin A as a result of lack of functional Zmpste24 or in
HGPS cells subjected to DNA damage (Liu et al., 2005; Varela
et al., 2005).
Our present findings provide a mechanistic basis for the
defects in DNA repair caused by mutations in lamin A. We
show that ATR kinase is mislocalised and/or mis-expressed in
cells expressing lamin mutants that are impaired in the DNA
damage response to UV and cisplatin. ATR normally resides
in the nucleus bound to chromatin and is directly complexed
with ATR-interacting protein, but details of its mechanism of
nuclear transport have not been reported. We suggest that the
mislocalisation of ATR might be attributed to loss of specific
binding sites on chromatin, leading to altered nuclear transport
properties, retention in the cytoplasm and subsequent
degradation. In response to DNA damage, replication protein
A (a single-stranded-DNA-binding protein) bound at the DNA
lesion is able to recruit the complex of ATR-interacting protein
and ATR, thus facilitating the phosphorylation of crucial
substrates such as -H2AX by ATR; this might involve
additional proteins such as claspin, minichromosome
maintenance proteins and RAD proteins (Bartek et al., 2004).
Mislocalisation of ATR by lamin mutants may thus lead to
impaired formation of -H2AX foci, which in turn reduces
recruitment of 53BP1, as seen with the same set of mutants.
Although lamin mutants do not directly affect ATM
localisation, we suggest that effects on ATR might be sufficient
to impair DNA repair pathways requiring both ATM and ATR
functions. As the mutants showing mislocalisation of ATR also
display altered localisation of emerin, we propose that normal
lamin-chromatin interactions are required for the correct
nuclear localisation of ATR and subsequent activation of the
ATR signalling pathway.
Our study has demonstrated that several lamin mutants
causing progerias and muscle-specific disorders induce
mislocalisation of emerin and aberrant localisation of ATR
prior to damage, resulting in defects in ATR signalling
pathways such as reduced phosphorylation of H2AX and
inadequate recruitment of 53BP1 to repair sites in response
to DNA damage in cell culture. With regard to disease
mechanisms, ectopic expression studies in an immortal cell
line such as HeLa do have potential limitations in interpretation
for the disease in the whole animal. However, in the context of
our findings, it may be noted that wastage of tissues is a
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hallmark of several laminopathies. Hence, impairment of DNA
repair processes ultimately leading to cell death might be a
more general mechanism that could contribute to pathogenesis
in some laminopathies, in addition to the well-documented
effects on tissue differentiation.
Materials and Methods
Plasmid constructs
Lamin A constructs were made as fusions with green fluorescent protein (GFP). The
wild-type GFP-lamin A construct has been described earlier (Mariappan and
Parnaik, 2005). Point mutations were introduced into lamin A cDNA by PCR-based
mutagenesis of the 1.4 kb HindIII fragment (502-1886 bp) in a two-step PCR using
the appropriate mutant primers and flanking normal primers. The mutated segments
were ligated to lamin A cDNA fragments to give full-length constructs. All
constructs were verified by automated DNA sequence analysis. To enable ectopic
expression of lamin A del50, appropriate fragments of lamin A cDNA were
amplified by PCR and religated so as to delete the 1819-1968 bp segment (amino
acids 607-656). All lamin constructs were expressed as GFP fusions from the
cytomegalovirus (CMV) promoter in the pEGFP-C vector. Mammalian expression
vectors for FLAG-tagged ATR and ATM kinases were generous gifts from P.
Ngheim (Massachusetts General Hospital, Charlestown, MA) and M. Kastan (St
Jude’s Children’s Research Hospital, Memphis, TN), respectively.
Cell culture, DNA transfection and treatment with DNA-
damaging agents
HeLa cells were grown in DMEM supplemented with 10% fetal bovine serum at
37°C in a humidified atmosphere containing 5% CO2. DNA transfections were
carried out with Lipofectamine PLUS (Invitrogen) according to the manufacturer’s
instructions. Transfection efficiencies were ~25%. At 24 hours after transfection,
cells were treated with 25 M cisplatin for 4 hours (or longer as indicated). For
treatment with UV irradiation, transfected cells were subjected to UV irradiation at
50 J/m2 and then allowed to recover in fresh medium for 30 minutes.
Immunofluorescence microscopy
HeLa cells were washed with phosphate-buffered saline (PBS) and then routinely
fixed by treatment with 3.5% formaldehyde for 10 minutes followed by 0.5% (v/v)
Triton X-100 for 6 minutes at room temperature, or with methanol at –20°C for 10
minutes for LA-2B3 antibody. Cells were then incubated with 0.5% gelatin in PBS
for 1 hour followed by incubation with first antibody for 1 hour and then biotinylated
second antibody and avidin-Cy3 for 1 hour each at room temperature. Samples were
mounted in Vectashield (Vector Laboratories) containing 1 g/ml DAPI. The primary
antibodies used were mouse monoclonal antibodies (mAbs) to lamin A/C (LA-2B3),
which stains the nuclear periphery (Jagatheesan et al., 1999), -H2AX from Upstate
Biotechnology, emerin (4G5) from Novocastra Laboratories, 53BP1 (H-300) from
Santa Cruz Biotechnology, and FLAG (M2) from Sigma-Aldrich. Secondary
antibody conjugates were from Jackson ImmunoResearch Laboratories, Molecular
Probes or Vector Laboratories. There was no crossreactivity of the fluorescent second
antibodies in control experiments in which primary antibodies were omitted.
Confocal laser-scanning immunofluorescence microscopy (CLSM) was carried out
with a Zeiss LSM510 META confocal microscope. Image analysis was done using
LSM510 META Software (Carl Zeiss), and images were assembled using Adobe
Photoshop 6.0. Quantitative analysis was carried out by inspection of n=100 cells
per sample in three separate experiments and values expressed as mean ± s.d.
Western blot analysis
HeLa cells were harvested, lysed in Laemmli’s sample buffer, boiled and
electrophoresed through SDS-10% polyacrylamide gels. Gels were electroblotted
onto PVDF membrane filters and blocked overnight in 5% BLOTTO in Tris-
buffered saline containing 0.1% Tween-20. Filters were incubated with primary
antibody for 2 hours, followed by secondary antibody for 1 hour. The primary
antibodies used were polyclonal antibodies to lamin A from Santa Cruz
Biotechnology, poly ADP-ribose polymerase-1 (PARP-1) from Roche Applied
Science and GFP from Clontech. Bound antibody was visualised using a
chemiluminescence kit (Roche Applied Science) for peroxidase-conjugated
secondary antibody (for PARP-1) or by colour reaction using nitroblue tetrozolium
and 5-bromo-4-chloro-indolyl phosphate for alkaline phosphatase-conjugated
secondary antibody (for lamin A and GFP).
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